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The postantibiotic effect (PAE) is the persistent inhibition of bacterial growth after
a brief exposure to an antibiotic. Most /J-lactams do not induce a PAE for
Gram-negative bacteria, but PAEs have been reported for carbapenems and penems.
This study investigated the effect of sequential doses of imipenem on the PAE for
Pseudomonas aeruginosa and Escherichia coli cultures in a chemostat. The PAE for
the bacterial population did not change even after six successive exposures to
imipenem. Nevertheless, screening of colonies isolated after repeated drug exposure
identified a single P. aeruginosa mutant whose imipenem PAE was shortened,
although the MIC was unchanged. The PAEs for the parent and mutant were studied
in vitro in batch culture by monitoring: (i) viable counts; (ii) electrical impedance of
the culture medium; (iii) incorporation of radiolabelled N-acetyl-D-glucosamine and
(iv) cell volume changes. PAEs for the parent and mutant were found to be
significantly different by all in-vitro methods used. Moreover, the median cell volume
in antibiotic-exposed cultures remained much smaller and less heterogeneous than in
the control cultures, even though both cultures were growing at the same rate. The
mutant was found to have a reduced expression of a 52 kDa outer membrane protein.
These observations suggest that factors in addition to suppression of bacterial growth
should be considered when studying the PAE. The PAEs of imipenem for the parent
and mutant were studied in a thigh infection model in leucopenic mice. Similar PAEs
were observed in vivo for both parent and mutant in one experiment and no PAEs
for either organism were found in a second experiment. This study showed that
although the PAE is a stable in-vitro phenomenon, the lack of correlation between
the in-vitro and in-vivo results warrants caution in attributing clinical significance to
the PAE of imipenem.
Introduction
Bacteria often do not resume normal growth for several hours after transient exposure
to antibiotics, a phenomenon often termed 'postantibiotic effect' (PAE). Many different
classes of antimicrobial induce PAEs, though not in all bacteria. PAEs of jS-lactams,
though often substantial for Gram-positive bacteria, are generally minimal or absent
for Gram-negative bacteria, which rapidly recover once the antibiotic is removed
(Bundtzen et al., 1981). The cabapenems and penems are an exception and have been
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widely reported to induce PAEs in Gram-negative bacteria in vitro (Bustamante et al.,
1984; Manek, Andrews & Wise, 1986; Chin & Neu, 1989; Nadler, Pitkin & Sheikh, 1989)
and to a lesser extent, in vivo (Gudmundsson, Vogelman & Craig, 1986; Renneberg &
Walder, 1989; Jabes, Rossi & Delia Bruna, 1992). In theory at least, such PAEs may
be of clinical value, allowing dosage intervals to be extended.
To be useful clinically, however, the PAE should be stable: it would be of little value
during therapy if bacterial populations were rapidly over-run by mutants that lacked
a PAE. Only two studies have examined the stability of the PAE (Karlowsky et al., 1993;
McGrath et al., 1993) to date. McGrath et al. (1993) found that PAEs of tobramycin
and temafloxacin for Pseudomonas aeruginosa decreased and increased respectively
during three successive exposures to these drugs. Karlowsky et al. (1993) reported that
PAEs of ciprofloxacin and gentamicin for Escherichia coli decreased over the course of
three exposures. Reductions in antibiotic susceptibility were also noted in repeatedly
challenged cultures and complicated analysis of the PAE responses. In contrast
McGrath et al. (1993) found no difference in the PAEs of imipenem for P. aeruginosa
after three exposures. Wu & Livermore (1990) suggested that mutants lacking a
/Mactam PAE are not rapidly selected because no change in the interdose recovery of
bacterial populations was noted when a chemostat culture of P. aeruginosa was
challenged with four successive doses of imipenem at 12 hourly intervals. In the present
study the effect of multiple dosage on the stability of the PAE for E. coli and P.
aeruginosa during repeated exposure to imipenem in a chemostat was investigated.
Investigations then proceeded to determine whether the PAE for individual cells within
the population was altered after exposure to imipenem. A PAE-lacking mutant was
found and characterised in vitro and in vivo.
Materials and methods
Bacterial strains, antibiotics and chemicals
Studies were performed on P. aeruginosa PAO1 (ATCC 15692) and E. coli 220 (clinical
isolate). A PAE mutant of P. aeruginosa PAO1, designated CM41, was isolated in the
present study and is described below.
Imipenem was obtained as powder from Merck Sharp and Dohme Ltd (Hoddesdon,
Herts.) In all in-vivo experiments, imipenem was used as a 1:1 combination with
cilastatin. The weights and concentrations of the imipenem/cilastatin mixture quoted in
this context relate solely to imipenem, cilastatin amounts being constant throughout.
Unless otherwise stated, all non-radioactive chemicals were obtained from the Sigma
Chemical Company (Poole, Dorset) or from BDH Chemicals Ltd (Poole, Dorset).
Radioactive compounds were obtained from Amersham International PLC (Aylesbury,
Bucks.). Commercial growth media were purchased from Unipath Ltd (Basingstoke,
Hants), except Don Whitley Impedance Broth (DWI) that was obtained from Don
Whitley Scientific Ltd (Shipley, W. Yorks.).
The carbon-limited sodium acetate medium described by Wu & Livermore (1990) was
used to grow P. aeruginosa cultures in the chemostat, whereas E. coli was grown in M9
medium (Roberts et al., 1957) pH 7-2, supplemented with filter-sterilised glucose ( 0 1 %
w/v).
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Animal studies
In-vivo experiments were carried out in pathogen-free, 6 week old female MAGF white
inbred mice (Ciba-Geigy Tier Farm, Sisslen, Switzerland) each weighing 20 + 1 g. No
treatment was carried out for the first 48 h after caging, to allow acclimatisation. Mice
were killed by asphyxiation with CO2, immediately dissected and then blood withdrawn
from the vena cava using heparinised syringes.
Leucopenia was induced in mice by two intraperitoneal doses (200 mg/kg each) of
cyclophosphamide (Asta-Werke Degussa Pharma Gruppe, Bielefeld, Germany), admin-
istered 72 and 48 h before infection (or drug administration in pharamcokinetic
experiments). Leucocytes were counted with a Sysmex CC-170M microcell counter (Tao
Medical Electronics Company, Kobe, Japan).
Susceptibility tests
Minimum inhibitory concentrations (MICs) were determined in 1 mL volumes of
Antibiotic Medium No. 3 (AMN3), appropriate chemostat media or standardised
mouse muscle homogenate (SMMH) prepared from mouse thigh. Inocula of 106 cfu/mL
were used. The MIC was defined as the lowest concentration of antibiotic necessary to
prevent visible growth after 18 h incubation at 37°C. The MIC in SMMH was defined
as the lowest concentration of antibiotic to prevent development of green pigmentation
due to pyocyanin and pyoverdin, as in the control tubes. Minimum bactericidal
concentrations (MBCs) were established by spotting ten 10/xL of the MIC broths on
to antibiotic-free nutrient agar plates and examining for growth after incubation for
18 h at 37°C.
PAE after repeated exposure to imipenem in the chemostat
The continuous culture system (Series 210 Bioreactor, LH Fermentation Ltd, Reading,
Berks.) consisted of a 2 L culture vessel with mechanical stirrer, thermostat-regulated
heater, aerator, oxygen electrode, pH electrode, foam detector and their respective
control modules. The dissolved oxygen level was 80% saturation, the agitation speed
was 500 rpm ± 100 rpm and the pH was 7-2. Polypropylene glycol was used as an
anti-foaming agent when required (< lmL/24h) . Inocula of 25 mL volumes of
overnight batch culture were added to 1000 mL of warm (37°C) medium in the
chemostat culture vessel. The culture was then incubated at 37°C for 18 h allowing
bacteria to reach stationary phase, after which addition of fresh medium was started
at a flow rate that gave a doubling time of 2 h. Cultures were grown for at least ten
doubling times, to allow steady state to be attained. Imipenem was then added to a final
concentration of 10 mg/L. Antibiotic was eluted from the culture by the inflow of fresh
medium, its half-life being equal to the doubling time.
Ten mL volumes of culture were removed at intervals for up to 72 h. Viable counts
were determined as described below. Once the viable count had returned to approxi-
mately its pre-dose level, about 24 h after addition of imipenem, a second identical dose
of drug was added and the fall and rise in bacterial numbers were monitored again. This
regimen, (10 mg/L every 24 h) was repeated for 6 days and was designed to promote
cells that recovered most quickly after exposure to antibiotic. The time for the viable
count to increase by 1 log after the antibiotic had fallen to its MIC was noted after each
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exposure. This full procedure was carried out on three separate occasions, each time
starting with the parent culture.
Screening of individual colonies from post exposure cultures for altered PAEs. One
colony per sampling interval was selected at random from spread plates prepared for
viable counts at 10-22 h after each addition of imipenem to P. aeruginosa cultures and
at 6-18 h after its addition to E. coli cultures. Their susceptibilities were determined by
diffusion tests with imipenem 10 /ig discs on nutrient agar plates. Isolates whose
inhibition zone diameters differed by >3 mm from those of the parent were discarded.
Isolates whose susceptibilities remained unchanged were retained on nutrient agar
slopes and their PAE responses to imipenem were measured by the impedance
technique. Those isolates with a shortened PAE were later examined by viable counts.
This screening procedure was carried out once for all isolates. The isolate whose PAE
response was shorter when measured by both methods was then studied in detail.
PAEs studied in batch culture
Viable counts. Overnight broth cultures were diluted 1000-fold with the appropriate
pre-warmed (37°C) broth to give c. 106cfu/mL. Two 25 mL volumes of the diluted
cultures were incubated at 37°C with continuous shaking at 150 rpm for 90 min, to yield
cells in mid-log growth. Freshly prepared antibiotic solution (lOmg/L) in broth was
then added to one flask, the other serving as a control. Incubation was continued for
90 min, when the antibiotic was removed by the addition of jS-lactamase (Broad
Spectrum j?-Lactamase Mixture SRI 13, Unipath Ltd) and the control culture was
diluted 1000-fold, to reduce the bacterial numbers to a level similar to that remaining
in the antibiotic-treated cultures. The amount of /?-lactamase completely hydrolysed the
antibiotic in 10 min (assayed spectrophotometrically). Regrowth of cells in both cultures
was followed by removing 1 mL samples at intervals for up to 300 min after drug
removal. These were diluted in peptone water (1 -5% w/v), using a ten-fold dilution series
and duplicate 100/^L volumes were spread on to pairs of nutrient agar plates. Colonies
usually were counted after 24 h incubation at 37°C.
The PAE was calculated as:
PAE = T-C; equation 1
where T was the period required for the viable count of the antibiotic-exposed culture
(test) to increase ten-fold after removal of antibiotic and C was the period for the
antibiotic-free culture (control) to increase ten-fold after the dilution step (McDonald,
Craig & Kunin, 1977). PAEs were determined in parallel for the parent and mutant.
PAE studies by impedance measurement. Exposure to imipenem and its removal were
as described above, except that cultures were grown in DWI broth rather than AMN3.
After antibiotic removal, 10 mL volumes of cultures were placed in appropriate
pre-warmed (37°C) polypropylene tubes in the impedance measuring system (RABIT,
Don Whitley Scientific Ltd). Conductivity was measured every 6 min during the next
24 h. As recommended by the manufacturer, growth was inferred once the conductivity
had changed by ^ 5 microSiemens in each of three consecutive 6 min recording
intervals.
The durations of PAEs were determined both from the periods for growth to be first
inferred and from the periods required to reach the maximum rate of change in
conductance. In the former case the PAE was calculated by subtracting from the period
The postantibiotic effect of imipenem 489
for growth to be first inferred in an antibiotic-exposed culture (Tnd) the period for
growth to be first inferred for a similar concentration of bacteria in an antibiotic-
unexposed culture (Cud), i.e.
PAE = rud — Cud. equation 2
In the latter case, the PAE was calculated by subtracting from the period for the rate
of change in conductance to be maximum in an antibiotic-exposed culture (rdS/dl), the
period for an originally identical bacterial concentration in an antibiotic-unexposed
culture to reach its maximum rate of change of conductance (CdS/dt) (viable counts were
performed to confirm that bacterial populations were comparable), i.e.
PAE = 7dS/dt - CdS/dt. equation 3
PAE studies by incorporation of radiolabelled ~N-acetyl-D-glucosamine (GlcNac).
Exposure to antibiotic and its removal were exactly as described above, except that the
inoculum was prepared from an overnight culture diluted 100-fold rather than
1000-fold. After removal of antibiotic, the OD540nms of both the control and test cultures
were adjusted to an OD of 0-08 by dilution with fresh pre-warmed AMN3.
Two mL volumes of the diluted cultures were dispensed into separate universal bottles
and GlcNac (3-5 mg/L) was added. Incubation was continued for 5 min, with shaking
in a water bath at 37°C. Subsequently, 4/iCi of radiolabelled [3H] GlcNac
(26-2 mCi/mg) was added. One hundred fiL samples were withdrawn at intervals for up
to 240 min, mixed with equal volumes of cooled trichloroacetic acid (TCA) 10% (w/v)
in the wells of a microtitre filtration plate (Multiscreen Filtration Plates, Millipore (UK)
Ltd, Watford, Herts.). The TCA-insoluble material was collected by filtration via a
MultiScreen Vacuum Manifold (Millipore (UK) Ltd), washed with two 200 n L amounts
of cooled TCA (10%), dried and radioactivity measured in a liquid scintillation counter
(Mini Beta Liquid Scintillation Counter, Model 1211, Wallac (UK) Ltd, Crownhill)
using Ultima Gold scintillant (Packard Instrument B.V.-Chemical Operations, Gronin-
gen, Netherlands).
The PAE was calculated according to the formula:
P A E = r c p m - C c p m ; equation 4
where Tcpm was the period required (after antibiotic removal and addition of precursor),
for the radioactivity in the TCA-insoluble material of the test culture to reach
10,000cpm/100 nh sample and Ccpm was the corresponding period for the control
culture to reach 10,000cpm/100fiL sample. The incorporated radioactivity in the
control cultures was rising exponentially with time when the activity per 100/iL sample
had reached this value.
PAE studies by measurement of changes in cell volume. Log phase cultures in AMN3
containing approximately 108cfu/mL were exposed to 10 mg/L imipenem for 90 min.
Antibiotic was removed by the addition of /?-lactamase. Control cultures were diluted
by a factor of 103, to give approximately the same number of cells as the test cultures.
Samples were withdrawn at intervals after the removal of antibiotic and diluted to give
approximately 5 x 105cfu/mL in 20 mL of a filtered solution comprising aqueous
formaldehyde 1-9% (w/v) in Cellpack (Toa Medical Electronics Company, Kobe,
Japan). Fifty /iL samples were aspirated through a 30 ^ m capillary electrode of a
Coulter Counter (Model ZM, Coulter Electronics Ltd, Luton Beds). The distribution
of cell size was determined by a channel analyser (Channellyzer 256, Coulter Electronics
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Ltd). At each sample point 20,000 to 25,000 cells were measured from each culture.
Background counts were performed with uninoculated broth, which was identically
diluted in Cellpack.
Outer membrane proteins of P. aeruginosa PAOl and CM41
Outer membrane proteins (OMPs) were examined from P. aeruginosa PAO1 and CM41
cultures that had been grown in AMN3 or SMMH.
Harvesting of bacteria grown in AMN3. Cultures that were grown: (a) overnight in
100 mL of AMN3 or (b) to log phase in 200 mL AMN3 without addition of antibiotic
or (c) to log phase in 400 mL AMN3 with antibiotic being added for 90min, as
described above. In the last case cells were harvested either immediately after removal
of antibiotic with /?-lactamase or after a recovery period of 1 h at 37°C. Harvesting in
all cases was by centrifugation at 10,000 g and 4°C for 15 min. After harvesting, the cells
were washed with 0-9% saline and resuspended in 5 mL 10 mM HEPES buffer, pH 7-4.
Growth and harvesting of bacteria in SMMH for OMP analysis. Overnight AMN3
cultures were diluted to give an OD540nm reading of 0-8; subsequently 0-3 mL portions
of the diluted cultures were added to 15 mL volumes of SMMH in 100 mL conical
flasks. The resulting SMMH cultures were incubated at 37°C with continuous shaking
at 150rpm for 20 h. Cells were then harvested by centrifugation at 10,000 g and 4°C
for 10 min, resuspended in culture volumes of 0-9% saline, and centrifuged at 8-5 g for
10 min. The pellet of intact murine cells was discarded. Bacterial cells were subsequently
collected by centrifugation at 10,000 g and 4°C for 15 min and resuspended in 2mL
10 mM HEPES buffer, pH 7-4. An uninoculated SMMH culture was treated identically
and subsequently electrophoresed to distinguish between bacterial and murine proteins
on SDS gels.
Extraction of outer membranes. Cell suspensions in HEPES buffer were disrupted by
passing twice through a French Pressure Mini-Cell (Aminco; SLM Instruments Inc,
Urbana, Illinois, USA) at 980 kg/cm2. Unbroken cells were sedimented by centrifu-
gation at 5000 g for 10 min and 4°C and discarded. Subsequent operations were as
described by Niven, Donga & Archibald (1989), except that samples containing 10/ig
protein per lane were separated by SDS-PAGE on 12% single concentration acrylamide
Mini-PROTEAN II gels (Bio-Rad Laboratories Ltd, Hemel Hempstead, Herts.).
Pharmacokinetics of imipenem in leucopenic mice
Administration of imipenem and preparation of plasma and muscle samples. In order
to establish the period for which the concentration of imipenem in plasma and in muscle
exceeded the MIC, single dose pharmacokinetics were determined. Fifty leucopenic mice
were each injected intraperitoneally with 200mg/kg imipenem in 400/zL volumes of
pyrogen-free sterile saline. At intervals, groups of five mice were killed.
To determine imipenem plasma concentrations, blood was withdrawn and immedi-
ately centrifuged for 5 min at 10,000 g. Plasma (approximately 250 ^ L per mouse) was
mixed with an equal volume of cooled buffer to stabilise inipenem. This consisted of
1 M MOPS buffer:ethylene glycol (1:1) pH 6-8 (Finch et al., 1986). The mixture was
quickly frozen on solid carbon dioxide and stored at -80°C.
To determine the concentrations of imipenem in muscle tissue, all muscle from the
left thigh was dissected from each mouse and rinsed in a cooled filter-sterilised buffer
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for stabilising imipenem in tissue (10HIM MOPS:ethylene glycol (1:1) pH 70). The
muscles from individual mice were blotted dry, weighed and then homogenised with a
Polytron tissue homogeniser (Kinematica, Lucerne, Switzerland) in 3 mL volumes of the
same buffer. The resulting homogenates were centrifuged at 4000 g at 4°C for 20 min.
One mL of the supernatant ('clarified muscle homogenate') was quickly frozen on solid
carbon dioxide and subsequently stored at — 80°C before bioassay.
Bioassay. Concentrations of imipenem in the plasma and muscle homogenate samples
were determined by an agar well diffusion assay using Antibiotic Medium Number 1
agar seeded with Micrococcus luteus ATCC 9341 (107cfu/mL). Wells were filled with
50 n L of samples or imipenem standards. For assays of imipenem in plasma, imipenem
standards of 128 to 0-06 mg/L as doubling dilutions in pooled mouse plasma were
diluted two-fold with the buffer for stabilising imipenem in plasma and quickly frozen
on solid carbon dioxide and stored at — 80°C. For assays of imipenem in muscle tissue,
imipenem standards of 128 to 006mg/L in doubling dilutions were prepared and
diluted in SMMH. These samples were also quickly frozen on solid carbon dioxide and
stored at -80°C.
Standards were repeated five times and samples repeated twice. After 18 h incubation
at 37°C, inhibition zone diameters were measured and the imipenem concentrations in
muscle (/ig/g) and plasma (mg/L) were calculated.
In-vivo PAE of imipenem
The PAEs of imipenem for P. aeruginosa PAOl and its PAE deficient mutant, CM41,
were studied in parallel in a thigh infection model in leucopenic mice. The experiment
was performed on two separate occasions. In each individual PAE experiment the level
of leucopenia was measured by bleeding five uninfected mice and counting their
leucocytes, as described above.
To prepare the inoculum, overnight broth (AMN3) cultures were diluted 1000-fold
in fresh warm (37°C) AMN3 and incubated at 37°C with shaking at 150 rpm for 8 h
until the cultures reached late log or early stationary phase. The cultures were then
mixed with equal volumes of filter-sterilised 20% (w/v) glycerol and stored at — 140°C
in 200 / JL aliquots, each containing 108cfu. These frozen stock cultures (2 x 200/zL
aliquots) were thawed when needed, diluted in 40 mL of fresh pre-warmed (37°C)
AMN3, and incubated at 37°C with shaking at 150 rpm for 3 h, to give log phase cells.
The OD^on,,, of the cultures was adjusted to 0-04 by dilution with AMN3, corresponding
to approximately 107cfu/mL. The number of cells was confirmed by viable count.
Leucopenic mice were infected with 107cfu from these log phase cultures by injection
of 200 pL volumes into left thigh muscle. In each experiment 65 animals were infected
with the parent strain and 65 with the mutant.
Imipenem (200mg/kg) was injected intraperitoneally 2h after infection, in 400/JL
volumes of pyrogen-free sterile saline into 30 mice from each group. At two hourly
intervals for the next 12 h, sets of five mice from each of the four groups (PAOl-infected,
treated, n = 30; PAOl-infected, untreated, n = 35; CM41-infected, treated, n = 30;
CM41-infected, untreated n = 35) were killed. The left thigh muscles were dissected,
rinsed in cooled saline, blotted dry and weighed. Muscles from the individual animals
were homogenised in 3 mL volumes of cooled saline, using a Polytron tissue homogen-
iser. The numbers of bacteria in each individual muscle homogenate were quantified.
Counts of the mutant CM41 were made after 48 h, since colonies were too small to
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count after 24 h incubation. Means and S.D.S of the numbers of bacteria per gram of
muscle were computed for the groups of five mice killed at each time interval.
The PAE was calculated by a method that took account of the spread of data from
individual animals at each time point. Linear regression analysis was performed on the
logarithms of the viable counts obtained from individual animals between 4 and 10 h
after infection for the mice that were treated with antibiotic and between 2 and 8 h for
the animals in the control groups. The regression coefficient (i.e. the slope of the log
viable count vs time graph) gave the bacterial growth rate, i.e. increase in log viable
counts per hour. The reciprocal of this value was the period required for a 1 log increase
in viable count, which corresponds to the period normally used as a basis for calculating
the duration of the PAE (equation 1). The PAE was calculated by the equation:
P A E = 7 m - C m ; equation5
where Tm was the period for the viable counts of bacteria from treated mice to increase
by 1 log; Cm was the period for a similar increase in the viable counts of bacteria in
untreated mice. Tm and Cm were measured from a time point 2 and 0 h after imipenem
administration respectively, by which time imipenem was no longer detectable in the
muscle homogenates of the treated mice and its concentration at the site of infection
was probably below the MIC (see Discussion).
Data analyses
The mean S.D. of the PAEs measured in vitro were calculated and compared by unpaired
/-tests. PAEs measured in vivo were compared by a modified /-test that compared pairs
of regression coefficients (i.e. bacterial growth rates calculated above) thus allowing use
of data from individual animals (Bailey, 1992).
Generation times (g) were calculated by linear regression analysis of plots of log
cfu/mL vs time or for cultures in mid-log phase or of log cfu/g on time, for bacteria
obtained from individual animals between 2 and 8 h after infection, as appropriate. The
regression coefficient (k) gave the growth rate. Thus:
g — log 2/k. equation 6
Results
PAE after repeated exposure to imipenem in chemostat
PAEs after successive doses of imipenem are shown in Table I. Even after six successive
exposures to imipenem, the PAE for both the E. coli and P. aeruginosa populations did
not change. The PAEs measured in the chemostat had an apparently longer duration
than those measured in batch culture. However, the definition of the PAE differs
between the two methods and so their results are not directly comparable. Firstly, in
the chemostat there was no comparison with a control; secondly, bacterial elution
continued during the PAE and some regrowth would be required to balance this factor;
thirdly, some antibiotic was still present whilst recovery was being measured, whereas
in batch culture experiments, antibiotic was completely removed before recovery was
measured.
Ninety P. aeruginosa colonies were examined from spread plates prepared for viable
counts to imipenem. Five isolates were discarded because they were less susceptible to
Table I. Duration of PAEs observed in continuous culture after successive doses of imipenem (peak
10 mg/L, r, /2 = 2h)
Number of
doses of
imipenem
1
2
3
4
5
6
PAE
experiment 1
9
8-6
8-4
9-5
8-4
9-3
(h) for E. coli
experiment 2
9-4
9-4
91
9-2
9-3
ND
220
experiment 3
8-8
9-3
8-8
8-5
9-4
8-3
PAE (h)
experiment 1
8-7
7-3
8-4
7-3
7-6
7-3
for P. aeruginosa PAO1
experiment 2
7-7
7-8
8-5
7-8
7-3
7-9
experiment 3
7-5
7-6
7-2
7-5
7-3
ND
ND, Not done.
The PAE was defined as the period required for the viable counts to increase by 1 log after the antibiotic
concentrations had fallen to the MIC.
Table II. Comparison of MICs, MBCs and PAEs for P. aeruginosa PAO1 and its PAE mutant, CM41
Values of parameter measured for
Parameter measured PAO1
0-5
1
1-5 + 0-2
1-6 + 0-2
1-5
0-7
015
2-5
3-0 + 0-2
CM41
0-5
1
0-2 + 0-2
0-6 + 0-1
0-3
0-3
015
2-5
1-0 + 0-2
Comparison of PAEs for PAO1
and CM4I by unpaired /-test
/> = I
In AMN3:
MIC of imipenem (mg/L)
MBC of imipenem (mg/L)
PAE of imipenem by viable counts (h)*
PAE of imipenem (10 mg/L) by incorporation method (h)*
PAE of imipenem (10 mg/L) by impedance method (h), dS/df
PAE of imipenem (10 mg/L) by impedance method (h), ttd''
In chemostat medium:
MIC of imipenem (mg/L)
MBC of imipenem (mg/L)
PAE of imipenem (3 mg/L) by viable counts (h)*
<00I°
<001"
"Significantly different.
''PAE is the mean + S.D. of three experiments.
rPAE measured in DWI broth and calculated from the period the cultures took to reach their maximum rate of change in conductance (see equation 3). PAE is derived
from a single experiment.
''PAE measured in DWI broth and calculated from the period for growth to be first inferred (see equation 2). PAE is derived from a single experiment.
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imipenem than their parent in disc susceptibility tests. The PAEs for the remaining
colonies were measured by impedance (and calculated according to equation 3) with the
parent strains tested in parallel. Two P. aeruginosa isolates had reduced PAEs. In one
case the PAE was 0-8 h shorter than the parent (0-7 cf. 1-5 h), in the other the PAE was
1-2 h shorter (0-3 cf. 1-5 h). When the PAEs were determined by viable counts, only the
latter isolate, designated CM41 was confirmed to have a shorter PAE than the parent
(0-1 cf. 1 -5 h). The PAE for the former isolate was 1-4 h and was discarded, whereas
CM41 was subsequently studied in detail (Table II). None of the 90 E. coli colonies
examined had a shortened PAE.
In-vitro characterisation of PAE mutant, CM41
In AMN3, generation times for both CM41 and its parent, PAOl were 32 min; in the
chemostat medium their generation times were both 58 min. However, P. aeruginosa
CM41 grew more slowly than its parent on nutrient agar: PAOl formed visible colonies
after 24 h incubation at 37°C, but CM41 required an additional 24 h incubation at room
temperature (c. 21 °C) before colonies were large enough to count.
MICs, MBCs and PAEs for the parent and mutant are compared in Table II. The
MICs and MBCs of antibiotics for this mutant did not differ from those for the parent
when measured in AMN3. P. aeruginosa PAOl and CM41 were as sensitive to
imipenem/cilastatin as to imipenem itself. When the MICs of imipenem/cilastatin for
P. aeruginosa PAOl and CM41 were determined in SMMH the values were four-fold
above those in AMN3 and eight-fold higher for CM41.
The PAEs of imipenem determined from viable counts and by the incorporation
of the peptidoglycan precursor GlcNac in AMN3 for P. aeruginosa CM41 were
significantly shorter than for P. aeruginosa PAOl (P <00l, unpaired /-test).
When measured by impedance, the PAE of imipenem for the parent was 1-5 h and
that for the mutant was 0-3 h when calculated from the period required for the rate
of change in conductance to be maximum (see equation 3) and 0-7 and 0-3 h
respectively when calculated from the period for growth to be first inferred (see
equation 2).
Because CM41 was isolated in the chemostat medium, its PAEs in this broth were
also considered. When bacteria were exposed to 3 mg/L imipenem (giving the same ratio
above the MIC as that observed with 10 mg/L in AMN3), the mean PAE for
P. aeruginosa PAOl was 30h and that for CM41 was 10h. These PAEs were longer
than those determined in AMN3, but the difference between them remained significant
(P <001 , unpaired /-test).
The stability of the mutant was not investigated, but its PAE deficiency was not lost
upon serial subculture (up to four) on antibiotic-free agar plates. The PAEs of
imipenem/cilastatin were not different from the PAEs of imipenem on its own for both
P. aeruginosa PAOl and for CM41.
Changes in cell volume during the PAE
Figures l(a) and (b) shows the cell size distributions of PAOl and CM41 cultures after
90 min exposure to imipenem. After a 90 min exposure to imipenem, the median cell
volume of both PAOl and CM41 cultures increased and the population became more
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heterogeneous. However, within 45min of antibiotic removal, the median cell
volumes in the imipenem-exposed cultures of both PAOl and CM41 became smaller
than in the control and cell dimensions became more homogeneous. Over the next
4-25 h the median volume of the CM41 cells increased whilst remaining smaller than
that of the control cultures, whereas the median volume of the antibiotic-exposed PAOl
cells did not increase. The findings are consistent with the shorter PAE for CM41 than
for PAOl. Changes of the viable counts of these cultures with time are shown in
Figure 2.
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Figure 1. Cell volume distribution in cultures of P. aeruginosa (a) PAOl and (b) CM41 during regrowth
after 90 min exposure or not to imipenem (lOmg/L). • , imipenem exposed culture; D, control culture. The
box indicates the 25th and 75th percentiles and the central line is the median. The points at the end of the
whiskers are the 10th and 90th percentiles. 1 femptolitre (fL) = 10~15 L.
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Figure 2. Regrowth curves of P. aeruginosa PAOI and CM41 cultures after 90 min exposure or not to
imipenem (10 mg/L) • . CM41 imipenem-exposed culture; O, CM41 control culture; • , PAOI imipenem-ex-
posed culture; D, PAOI control culture.
Outer membrane proteins of P. aeruginosa PAOI and CM41
When OMP profiles of cultures grown in AMN3 were examined, a protein with a
molecular weight of 52 kDa was present in consistently smaller amounts in extracts from
mol wt
(kDa)
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31
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Figure 3. SDS-PAGE, on a 12% single concentration gel, of OMPs from P. aeruginosa PAOI (A) and
CM41 (B) grown in AMN3. Lanes: 1, overnight culture; 2, log-phase culture; 3, 0 min after antibiotic removal;
4, 60 min after antibiotic removal. Lane 0 contains molecular weight standards. The 52 kDa protein, present
in smaller amounts in CM41 than in PAOI, is arrowed.
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Figure 4. SDS-PAGE, on a 12% single concentration gel, of OMPs from P. aeruginosa PAO1 (A) and
CM41 (B) grown overnight in SMMH (lane 1) and in AMN3 (lane 2). Lane 3 contains uninoculated SMMH.
Lane 0 contains molecular weight standards. The 52 kDa protein is arrowed.
the mutant CM41 than from the parent PAO1 (Figure 3). This occurred whether
or not the cells were exposed to imipenem. However, when mutant CM41 was
grown in SMMH, the 52 kDa protein was synthesized at similar levels in both the parent
and mutant (Figure 4). Moreover, in these conditions the amount of this protein was
similar to that present in PAO1 after growth in AMN3.
Pharmacokinetics of imipenem in leucopenic mice
The dosage regimen used to induce leucopenia resulted in a mean + S.D. leucocyte
count of 1040 + 210 cells/^L (94% reduction). The dosage regimen was
lethal to 8% (14/175) of the mice. All deaths occurred within 24 h of the
second injection.
Bioassay allowed the detection of ^0-25 mg/L imipenem in plasma and ^0-5 ng
imipenem in muscle homogenates. Imipenem concentrations in plasma and muscle
homogenates from leucopenic mice, after a single 200 mg/kg intraperitoneal dose are
shown in Figure 5. The peak imipenem concentrations were 146mg/L in plasma and
39-6/xg/g in muscle and the half-lives in plasma and in muscle were 20 and 23min
respectively. Imipenem was detectable in the muscle within 5 min of the intraperitoneal
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injection and no longer detectable (i.e. <O-5/tg/g) 2h after injection. The antibiotic
concentrations in plasma exceeded the MIC for the test strains for 2 h. Those in muscle
homogenate were above MICs for c. 45 min; however, inhibitory concentrations almost
certainly applied for longer in the interstitial fluid of the muscle tissue (see Discussion).
In vivo PAEs
Time course of infection. The growth of P. aeruginosa PAOl and CM41 in
imipenem-treated and -untreated mice is shown in Figure 6. Organisms were recovered
in pure culture. Four h after infection, and 2 h after dosage, no antibiotic remained
detectable in the mice. Between 4 and 10 h after infection the bacterial counts in the
antibiotic-untreated animals increased exponentially but the infection remained
localised in the thigh muscle. After 12 h, bacteria appeared in the blood untreated
animals and the number of cfu/g muscle stabilised.
Bacterial growth rates. In both experiments A and B the inocula of P. aeruginosa
PAOl and CM41 were matched to ±0-5 log cfu/g muscle. The leucopenia attained
in each experiment was similar to within 700 cells//iL. The generation time of
P. aeruginosa PAOl was 61 min (experiment A and B) and that of CM41 was 77 min
and 97 min in experiment A and B respectively. Although these values were not
identical, the regression coefficients of log viable counts against time were not
significantly different between the parent and the mutant ( / > > 0 1 , comparison of
regression coefficients, Bailey 1992). Moreover, although the mutant tended to grow
more slowly in experiment B than in experiment A, this difference was not statistically
significant.
Killing and regrowth of bacteria. In experiment A, the viable count of P. aeruginosa
PAOl decreased by log 2-38 cfu/g muscle within 2 h after injection of imipenem and that
of P. aeruginosa CM41 decreased by log 1-88 cfu/g muscle (Table HI). In experiment
B, the viable count of P. aeruginosa PAOl decreased by log 2-47 cfu/g muscle within
2 h after injection of imipenem and that of/3, aeruginosa CM41 by log 1-41 cfu/g muscle
1000
20 40 60 80 100 120
Time after injection (min)
140
Detection
limit in
muscle Dl8sma
160 180
Figure 5. Imipenem concentrations • , /jg/g in muscle; • , mg/L in plasma. Each point represents the mean
of the results from five mice. Error bars indicate S.D.
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Figure 6. (a) Experiment A; (b) experiment B. O Mice infected with mutant, CM41 and untreated; • , mice
infected with mutant, CM41 and treated with imipenem; • • mice infected with parent, PAO1 and untreated;
• , mice infected with parent, PAO1 and treated with imipenem; Each point represents the mean viable count
(cfu/g muscle) from five mice. Error bars indicate S.D.
(Table III). The difference in the bactericidal activity of imipenem in the two
experiments was not statistically different (P = 0-77, unpaired /-test).
The durations of the PAEs observed in the individual experiments are shown in
Table III. As no significant difference in growth rates of PAO1 and CM41 was found
in untreated mice, the growth rates of these organisms in treated animals were compared
in order to establish whether there was a significant difference in the PAEs of imipenem
for P. aeruginosa PAO1 and CM41 in each experiment. In experiment A, the PAEs of
imipenem for P. aeruginosa PAO1 and CM41 were 10 and 1-6 h respectively. The PAEs
were not significantly different from each other (P>0l comparison of regression
coefficients, Bailey, 1992). In experiment B, the PAEs of imipenem for P. aeruginosa
PAO1 and CM41 were found to be -0-9 and —1-8 h respectively. These PAEs were
also not significantly different from each other ( P > 0 1 comparison of regression
coefficients, Bailey 1992), but were significantly different from the PAEs measured in
the first experiment (P < 0 1 unpaired /-test).
Table III. Comparison of generation times, extent of killing and the PAEs of imipenem for P. aeruginosa in vivo, determined in
separate experiments
Log cfu/g in muscle
Decrease in log
Generation time before 2 h after cfu/g, 2 h after
Organism Experiment (min) imipenem injection imipenem injection imipenem injection PAE (h)
PAO1
CM41
flPAOl
CM41
A
A
B
B
61
77
61
97
707
6-48
7-59
7-23
4-69
4-60
512
5-82
2-38
1-88
2-47
1-41
10
1-6
-0-9
-1 -8
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Discussion
/S-Lactams have been used more extensively than any other group of antibiotics. They
are relatively non-toxic to man but their activity depends on their serum or tissue
concentrations exceeding MICs for the pathogen (Drusano, 1988); as the half-lives of
many of these compounds are short, frequent dosing may be needed. A PAE would
potentially allow greater tolerance of delayed administration. Although PAEs of these
compounds have been widely claimed, only one study (McGrath et al., 1993) examined
the stability of /?-lactam PAEs following multiple doses. The results obtained in a
chemostat in our study for P. aeruginosa and E. coli agree with those of McGrath et al.
(1993) for P. aeruginosa in batch culture experiments, in that multiple doses of imipenem
did not cause gross over-run of cultures by mutants with a shortened PAE. This suggests
that the PAE is a stable phenomenon, which would be clinically favourable in assessing
the possible significance of the PAE. However, some bacterial cells may have a
shortened PAE. Wilson & Rolinson (1979) demonstrated, using differential interference
contrast microscopy, that individual Staphylococcus aureus cells within a culture
exhibited variable periods of growth suppression after exposure to penicillin. Colonies
were therefore selected at random from plates inoculated with samples taken from
the chemostat. Those isolates for which susceptibility to imipenem had not changed
were screened for a shortened PAE of imipenem using the impedance technique
since this allowed rapid screening of many samples. However, this screening method did
not allow the screening of sufficient samples to establish the frequency of mutation
to a shorter PAE and thereby establish whether exposure to imipenem increased
this frequency. Nevertheless, a single P. aeruginosa colony, designated CM41, was
found to have a consistently shorter imipenem PAE compared with that of its parent.
The isolation of a PAE-lacking mutant should help to elucidate the basis of the PAE
of carbapenems and penems. To date no previous PAE deficient mutant has been
reported.
Numerous in-vitro experiments confirmed a difference in the PAE response for
PAO1 and CM41. In batch culture the PAE of imipenem for the mutant, CM41
was significantly shorter than that for the parent. PAEs of imipenem were also
shorter for CM41 than for PAO1 when measured by impedance and by the incorpor-
ation of radiolabelled GlcNac. The former method measured gross cellular metab-
olism whereas the latter measured peptidoglycan synthesis. Despite its shortened
PAEs, the mutant had unaltered susceptibilities to the antibiotics studied, suggesting
that the primary determinant of the PAE differed from the primary target of anti-
biotic action. Moreover, no differences between growth rates of parent, PAO1, and
mutant CM41, were noted in liquid media (AMN3 or chemostat medium); however,
CM41 formed smaller colonies on agar, suggesting slower growth and/or smaller cell
size.
Shortly after drug removal, imipenem-exposed cells of both PAO1 and CM41 became
smaller than the unexposed cells and had a more homogenous cell size. Subsequently,
the median volume of P. aeruginosa CM41 cells gradually increased, but did not return
to that of antibiotic-untreated cultures within the 5 h monitoring period, whereas the
median volume of PAO1 cells remained constant and much smaller than that of
antibiotic-untreated cultures. The tendency of CM41 cells to resume a normal cell size
distribution after exposure to imipenem was consistent with its shorter PAE: it should
be pointed out that 3 h after antibiotic removal (after the end of the PAE as defined
in equations 1, 2, 3 and 4) the cells of both PAO1 and CM41 remained smaller than
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those in control cultures. Discrepancies between the PAE measured by viable counts
and the period before which cells resumed normal morphology were also noted by Guan
& Burnham (1992). They found that E. coli cells did not resume normal cell size for
at least 4 h after treatment with the quinolone enoxacin, whose PAE was 0-7 h. Thus
changes in cell size should be considered in addition to inhibition of bacterial growth,
when studying the PAE.
When grown in AMN3, CM41 lacked a 52 kDa OMP that was present in PAOl. This
protein had a molecular weight close to that reported (45 to 49 kDa; Trias & Nikaido,
1990) for the D2 'carbapenem specific' porin of P. aeruginosa. However, its identity as
D2 is open to question: loss of D2 protein from P. aeruginosa is generally associated
with imipenem resistance (Trias & Nikaido, 1990), but CM41 was as susceptible as
PAOl, in AMN3. There are no obvious reasons why loss of this protein should result
in a shorter PAE. When cells were grown in SMMH instead of AMN3, the 52 kDa
protein was expressed as strongly in CM41 as in PAOl. Moreover, there was no
difference between the PAEs of imipenem for PAOl and CM41 when studied in vivo
in the mouse thigh infection model. It is therefore possible that the amount of the
52 kDa OMP present in a cell may be related to its PAE response. It would be
interesting to determine whether CM41 could show a PAE to imipenem when grown
in vitro in SMMH. Detection of PAE in SMMH would provide strong support for the
proposed role of the 52 kDa protein in the induction of a PAE of imipenem. The
detection of this OMP by fluorescent antibodies could be used as the basis for the rapid
screening of individual cells for an imipenem PAE.
The PAEs of imipenem for PAOl and CM41 were investigated in an animal model
to establish whether in-vitro findings could be confirmed in vivo. If differences between
the PAEs for PAOl and CM41 could be confirmed in vivo, then the significance of PAE
might be established. Antibacterial treatment entailed a single 200 mg/kg intraperitoneal
dose of imipenem, giving an antibiotic concentration above the MIC for 120 min in
plasma. Imipenem concentrations in muscle homogenate remained above MIC for only
45 min. However, as imipenem does not readily enter mammalian cells, inhibitory
concentrations in interstitial fluid seem certain to have persisted for longer (Carbon,
1990). So it is likely that in vivo, the bacteria in interstitial fluid were exposed to
antibiotic above the MIC for at least 90 min, as in the in-vitro experiments.
Infection experiments were performed on two separate occasions, designated A and
B. In experiment A the PAEs for PAOl and CM41 were 10 and 1-6 h respectively
whereas in experiment B the PAEs for PAOl and CM41 were negative, being —0-9 and
— 1 -8 h respectively. Whilst it is difficult to reconcile these two divergent sets of results,
the one consistent point from both experiments was that the PAEs for PAOl and CM41
were not significantly different from each other. This was in contrast to the in-vitro
situation where the PAE of imipenem was significantly and consistently shorter for
mutant CM41 than for parent, PAOl as assayed by a range of methods.
The large variation in the results between the in-vivo experiments A and B is probably
due to natural variation amongst mice. The source of this variation is, however,
uncertain and was not related to the degree of leucopenia, which was similar in the
animals used for both experiments. Variation amongst the bacterial cultures is a less
likely explanation since the same inoculum was used for both experiments; moreover
the growth rates of bacteria in untreated mice did not differ significantly between
experiment A and B. The bactericidal activity of imipenem did not differ between the
two experiments.
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Gudmundsson et al. (1986) also observed considerable variation in the PAEs
observed in vivo. These authors observed PAEs of imipenem for P. aeruginosa ATCC
27853 of 1-4 h and 4-6 h in two experiments. On the other hand, Renneberg & Walder
(1989) did not observe such high inter-run variation in the PAE of imipenem for
P. aeruginosa ATCC 27853. These groups, however, used different models:
Gudmundsson et al. (1986) used a thigh infection model in neutropenic mice, whereas
Renneberg & Walder (1989) used a cotton thread infection model in normal mice. The
latter authors also observed in-vitro PAEs of imipenem for P. aeruginosa ATCC 27853
of 1-8 + 0-3 h. Thus demonstration of PAE in vitro seems to correspond to PAE in vivo.
However, Hessen, Pitsakis & Levison (1988), working with a rat endocarditis model,
failed to detect an in-vivo PAE of imipenem for a strain of P. aeruginosa which had
a 3 h PAE in vitro. Likewise, although the combination of imipenem and gentamicin
had a 5-4 h PAE in vitro, it gave no PAE in vivo (Hessen et al., 1988). Furthermore,
Jabes et al. (1992) did not observe an in-vitro PAE of the penem FCE 24964 for
Klebsiella pneumoniae and E. coli after exposure to 5 x MIC for 2 h. However, when
the PAE (of its orally-absorbed dioxolemethyl ester, FCE 25199) was studied in a tissue
cage fluid infection model in mice, PAEs exceeding 5 h were observed. Overall,
examination of reports of in-vivo PAEs of carbapenems and penems and our own
results suggests the need for caution in drawing conclusions about their in-vivo PAEs
from in-vitro results.
In man, imipenem is usually administered at 6 hourly intervals (i.e. four-times a day).
The peak serum concentration is c. 35 mg/L in healthy subjects following a 0-5 g
intravenous dose and the half-life is 1—1-4 h (MacGregor, Gibson & Bland, 1986). In
order to decrease the dosage frequency to three times a day (i.e. to administer it at
8-hourly intervals) the compound should induce a PAE of > 2 h in vivo. Thus, PAEs
of < 2 h of imipenem are unlikely to be clinically useful. PAEs measured in vitro and
in vivo in this study were less than 2 h. Imipenem has an approximately four-fold shorter
half-life in mice than in humans (Fliickiger, Segessenmann & Gerber, 1991). Since the
duration of the PAE is related both to the concentration of drug and to the duration
of exposure, extrapolation of the animal data to man is complicated. In particular, it
seems likely that the mouse infection models will underestimate the likely duration of
any PAE in man. Use of infection models in mice with impaired renal function, such
as that described by Craig, Redington & Ebert (1991) or models in which drug is
administered in decreasing doses at short intervals to simulate human pharmacokinetics
in mice (Fliickiger et al., 1991) should result in a longer PAE of imipenem. Whilst these
in-vivo experiments considered only one strain and mutant in a single experiment, they
do underscore the difficulty of extrapolating in-vitro data to the in-vivo situation, since
these results suggest little consistency in PAE response to imipenem in vivo, even with
organisms that showed a consistent in-vitro PAE response.
In conclusion, this study has shown that repeated exposure to imipenem does not
result in a rapid selection of mutants which lack a PAE. This showed that the PAE for
individual strains is a stable in-vitro phenomenon. However, a single P. aeruginosa
mutant which lacked an imipenem PAE was isolated. The basis of the mutation is
currently not known, but a 52 kDa OMP was present in smaller amounts in a
P. aeruginosa mutant with a shortened PAE. Moreover, following antibiotic exposure,
cells were found to be smaller than antibiotic-unexposed cells. Although the significance
of such smaller cells is uncertain future studies of the PAE should consider such factors
in addition to suppression of bacterial regrowth as measured by viable counts.
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Moreover, this study has shown that caution is warranted in inferring any clinical
significance of the PAE of imipenem from in-vitro data.
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